Understudied cell in the brain could be key to treating glioblastoma

Glioblastoma is one of the most treatment-resistant cancers, with those diagnosed surviving for less than two years. In a new study, researchers have found that a largely understudied cell could offer new insight into how the aggressive, primary brain cancer is able to resist immunotherapy.

Glioblastoma is one of the most treatment-resistant cancers, with those diagnosed surviving for less than two years. In a new study, researchers have found that a largely understudied cell could offer new insight into how the aggressive, primary brain cancer is able to resist immunotherapy.

Read more https://www.sciencedaily.com/releases/2023/12/231212112310.htm